188 related articles for article (PubMed ID: 22072052)
1. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.
Mattheolabakis G; Nie T; Constantinides PP; Rigas B
Pharm Res; 2012 Jun; 29(6):1435-43. PubMed ID: 22072052
[TBL] [Abstract][Full Text] [Related]
2. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration.
Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN
Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
[TBL] [Abstract][Full Text] [Related]
4. Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo.
Nie T; Wong CC; Alston N; Aro P; Constantinides PP; Rigas B
Br J Pharmacol; 2012 Jun; 166(3):991-1001. PubMed ID: 22141583
[TBL] [Abstract][Full Text] [Related]
5. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
Sun Y; Rowehl LM; Huang L; Mackenzie GG; Vrankova K; Komninou D; Rigas B
Breast Cancer Res; 2012 Jan; 14(1):R20. PubMed ID: 22293394
[TBL] [Abstract][Full Text] [Related]
6. PEGylated liposomes modified with LHRH analogs for tumor targeting.
He Y; Zhang L; Song C
J Control Release; 2011 Nov; 152 Suppl 1():e29-31. PubMed ID: 22195906
[No Abstract] [Full Text] [Related]
7. A novel ibuprofen derivative with anti-lung cancer properties: synthesis, formulation, pharmacokinetic and efficacy studies.
Cheng KW; Nie T; Ouyang N; Alston N; Wong CC; Mattheolabakis G; Papayannis I; Huang L; Rigas B
Int J Pharm; 2014 Dec; 477(1-2):236-43. PubMed ID: 25311177
[TBL] [Abstract][Full Text] [Related]
8. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X
Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567
[TBL] [Abstract][Full Text] [Related]
9. Phospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models.
Xie G; Sun Y; Nie T; Mackenzie GG; Huang L; Kopelovich L; Komninou D; Rigas B
J Pharmacol Exp Ther; 2011 Jun; 337(3):876-86. PubMed ID: 21422165
[TBL] [Abstract][Full Text] [Related]
10. Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation.
Matbou Riahi M; Sahebkar A; Sadri K; Nikoofal-Sahlabadi S; Jaafari MR
Int J Pharm; 2018 Apr; 540(1-2):89-97. PubMed ID: 29371019
[TBL] [Abstract][Full Text] [Related]
11. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
12. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
14. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
[TBL] [Abstract][Full Text] [Related]
15. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
16. Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.
Zhou X; Tao H; Shi KH
Drug Des Devel Ther; 2018; 12():1-8. PubMed ID: 29296076
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
Cosco D; Paolino D; Cilurzo F; Casale F; Fresta M
Int J Pharm; 2012 Jan; 422(1-2):229-37. PubMed ID: 22093954
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells.
Yang T; Choi MK; Cui FD; Lee SJ; Chung SJ; Shim CK; Kim DD
Pharm Res; 2007 Dec; 24(12):2402-11. PubMed ID: 17828616
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
20. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
